Microbicidal Polymer Spray
Tegsal is developing an antimicrobial polymer platform technology. They recently completed an NSF I-Corps cohort, which led to significant validation of commercial potential of their technology. Currently, they are investigating the applicability and impact of their technology across multiple clinical areas of interest, including as a multi-modal wound dressing prehospital trauma and combat casualty care.
Collaborators: Luke Duncan, MS, MBA, Elizabeth Schiesser, MSc and Barry Marston
Learn more about Dr. Park